Cite
APA Citation
Di Raimondo, C., Abdulla, F. R., Zain, J., Querfeld, C., & Rosen, S. T. (2019). rituximab, lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B‐cell lymphoma, leg type. British journal of haematology, 187, e79–e82. http://access.bl.uk/ark:/81055/vdc_100094617029.0x00005f